WELLINGTON MANAGEMENT GROUP LLP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,521,301
+7.0%
1,045,652
+2.6%
0.00%0.0%
Q2 2023$15,435,351
+4.9%
1,019,508
+0.5%
0.00%0.0%
Q1 2023$14,709,569
+7.7%
1,014,453
+0.4%
0.00%0.0%
Q4 2022$13,659,946
-13.9%
1,010,351
+0.3%
0.00%0.0%
Q3 2022$15,874,000
-15.1%
1,007,246
-34.4%
0.00%
-25.0%
Q2 2022$18,707,000
-21.5%
1,535,883
-39.6%
0.00%0.0%
Q1 2022$23,816,000
-54.9%
2,543,102
-18.3%
0.00%
-50.0%
Q4 2021$52,797,0003,114,0060.01%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders